Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00012924
DRKS00012924
Recruiting
Not Applicable

Evaluation of treatment regimes in patients with cystic fibrosis and pulmonary excerbations (PEx) - EvPEx

Klinik für Pädiatrie m. S. Pneumologie und ImmunologieCampus Rudolf Virchow Klinikum0 sites100 target enrollmentSeptember 22, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsE84.0Cystic fibrosis with pulmonary manifestations

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
E84.0
Sponsor
Klinik für Pädiatrie m. S. Pneumologie und ImmunologieCampus Rudolf Virchow Klinikum
Enrollment
100
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2017
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Pädiatrie m. S. Pneumologie und ImmunologieCampus Rudolf Virchow Klinikum

Eligibility Criteria

Inclusion Criteria

  • •Included in the study are:
  • •1\.Patients with CF and acute pulmonary exacerbation (\= 2/6 points in clinical symptome score)
  • •2\.Patients aged \= 6 and \= 75
  • •3\.Competent patients who have signed the written informed consens
  • •4\.Patients able to perform a lung function

Exclusion Criteria

  • •Not included in the study are:
  • •1\. Patients who have undergone a lung transplantation
  • •2\. Patients aged \< 6 or \> 75
  • •3\. Incapacitated patients or patients who have not signed the written informed consens
  • •4\. Patients unable to perform a lung function

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Pattern of treatment in metastatic Breast Cancer PatientsHealth Condition 1: C509- Malignant neoplasm of breast of unspecified site
CTRI/2023/05/052157Tata Memorial Centre
Active, not recruiting
Phase 3
Evaluation of a standard treatment regimen of anti-tuberculosis drugs for patients with MDR-TB
CTRI/2017/09/009693The international Union Against Tuberculosis and lung diseases
Not yet recruiting
Not Applicable
Evaluating a new treatment regimen for patients with multidrug-resistant TB (MDR-TB)HIV/AIDSTuberculosis
PACTR201409000848428university of Cape Town Lung Institute256
Completed
Not Applicable
Effect of N- acetyl cysteine on H.PyloriDyspepsia.dyspepsia
IRCT201108197302N2Vice – Chancellery of Research & Technology Affairs, Kermanshah University of Medical Sciences115
Active, not recruiting
Not Applicable
Evaluation of a treatment regimen for acromegaly
EUCTR2010-023674-39-ATÖsterreichisches Akromegalie Register